Publicaciones en las que colabora con ANDREA ACEBES HUERTA (10)

2016

  1. Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

    OncoImmunology, Vol. 5, Núm. 2

2015

  1. Desarrollo de estrategias de activación de la respuesta inmune antitumoral mediada por células NK

    Desarrollo de estrategias de activación de la respuesta inmune antitumoral mediada por células NK

  2. NKG2D signaling in cancer immunosurveillance

    International Journal of Cancer, Vol. 136, Núm. 8, pp. 1741-1750

  3. Pleiotropic anti-angiogenic and anti-oncogenic activities of the novel mithralog demycarosyl-3D-ß-D-digitoxosyl-mithramycin SK (EC-8042)

    PLoS ONE, Vol. 10, Núm. 11

2014

  1. Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

    PLoS ONE, Vol. 9, Núm. 10

  2. Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

    BioMed Research International, Vol. 2014

  3. Molecular bases for the regulation of NKG2D ligands in cancer

    Frontiers in Immunology

2013

  1. Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition

    OncoImmunology, Vol. 2, Núm. 9

2012

  1. Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: Association with soluble MICA shedding

    Cancer Immunology, Immunotherapy, Vol. 61, Núm. 8, pp. 1201-1210

2010

  1. Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

    Leukemia and Lymphoma, Vol. 51, Núm. 10, pp. 1829-1836